calendar
4,684 catalysts · 4,396 phase readout · 2,291 8k filing · 282 earnings · 172 phase 2 completion · 73 phase 1 completion · 71 drug shortage
next 91 dayslessmore
MonWedFri
4,684 catalysts · 4,396 phase readout · 2,291 8k filing · 282 earnings · 172 phase 2 completion · 73 phase 1 completion · 71 drug shortage
Sponsor: The Hong Kong Polytechnic University. Phase: . Conditions: Postpartum Depression (PPD)
Sponsor: University of Limerick. Phase: . Conditions: Frailty at Older Adults, Prostate Cancer
Sponsor: University of Southern California. Phase: NA. Conditions: Femoral Neck Fractures
Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Kidney Stone
Sponsor: Zealand Pharma. Phase: PHASE3. Conditions: Short Bowel Syndrome
Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Cancer, Depression Secondary to Other Disease, Cancer Survivor
Sponsor: Beth Israel Deaconess Medical Center. Phase: NA. Conditions: Long COVID, Post-Acute Sequelae of COVID-19, COVID Long-Haul
Sponsor: Takeda. Phase: . Conditions: Lysosomal Disease
Sponsor: ECOG-ACRIN Cancer Research Group. Phase: NA. Conditions: Acute Promyelocytic Leukemia With PML-RARA, t(15;17)
Sponsor: University Hospital, Akershus. Phase: . Conditions: Fatigue Post Viral
Sponsor: Riphah International University. Phase: NA. Conditions: Stroke
Sponsor: Genmab. Phase: PHASE3. Conditions: Diffuse Large B-Cell Lymphoma
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Phase 2 Study, MCL, BTKi, Rituximab, Glofitamab
Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Hemophilia A
Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Overweight, Obesity
Sponsor: HealthPartners Institute. Phase: . Conditions: Alzheimer Disease
Sponsor: National Cancer Institute (NCI). Phase: NA. Conditions: Neurofibromatosis Type 1
Sponsor: SurGenTec LLC. Phase: . Conditions: Intra-facet ION 3D Facet Screw System
Sponsor: Mayo Clinic. Phase: NA. Conditions: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis
Sponsor: Cairo University. Phase: NA. Conditions: Interimplant Mucosa
Sponsor: AbbVie. Phase: PHASE4. Conditions: Open-angle Glaucoma, OAG
Sponsor: Wang Jianhui. Phase: . Conditions: Bronchopulmonary Dysplasia
Sponsor: Institute of Oncology Ljubljana. Phase: PHASE4. Conditions: Breast Cancer, Adherence, Medication
Sponsor: Check Point R & D Ltd. Phase: NA. Conditions: Sepsis
Sponsor: Chulalongkorn University. Phase: PHASE2. Conditions: Hemophilia A Patient
Sponsor: Pennington Biomedical Research Center. Phase: . Conditions: BMI>40
Sponsor: Children's Hospital Medical Center, Cincinnati. Phase: PHASE2. Conditions: Migraine, Migraine Disorders
Sponsor: Radiopharm Theranostics, Ltd. Phase: EARLY_PHASE1. Conditions: HER2 Gene Mutation, Advanced Solid Tumors
Sponsor: Ottawa Heart Institute Research Corporation. Phase: PHASE3. Conditions: Radial Artery Occlusion
Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: NA. Conditions: Ventricular Arrhythmia
Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Breast Cancer, Cancer of the Breast
Sponsor: Ankara University. Phase: NA. Conditions: Thyroid Cancer, Differentiated Thyroid Cancer
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Phase: NA. Conditions: Cardiac Arrest (CA)
Sponsor: Hospital Universitari Vall d'Hebron Research Institute. Phase: PHASE4. Conditions: Febrile Neutropenia (FN), Pediatric Cancer, Hematologic Malignancies, Solid Tumors, Invasive Bacterial Infection
Sponsor: Spaulding Rehabilitation Hospital. Phase: NA. Conditions: Stroke, Hemiparesis
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE2. Conditions: Liver Transplant, Hepatocellular Carcinoma Recurrent, Systemic Treatment
Sponsor: Senem Duman. Phase: NA. Conditions: Spinal Cord Injury, Neurogenic Bowel Dysfunction
Sponsor: Shanghai Mental Health Center. Phase: . Conditions: Schizophrenia
Sponsor: Stanford University. Phase: NA. Conditions: Type 1 Diabetes
Sponsor: Hoffmann-La Roche. Phase: . Conditions: Breast Cancer
Sponsor: Dr. Steven Brooks. Phase: NA. Conditions: Out-Of-Hospital Cardiac Arrest, Heart Arrest, Heart Diseases, Cardiovascular Diseases
Sponsor: University of Michigan Rogel Cancer Center. Phase: PHASE2. Conditions: Oropharynx Cancer, HPV-Related Carcinoma
Sponsor: NRG Oncology. Phase: PHASE1. Conditions: Advanced Esophageal Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage II Esophageal Adenocarcinoma AJCC v8, Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8, Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8, Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage III Esophageal Adenocarcinoma AJCC v8, Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8, Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8, Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8, Unresectable Gastroesophageal Junction Adenocarcinoma, Squamous Cell Carcinoma, Squamous Cell Cancer
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer, Lobular Breast Carcinoma, Breast Carcinoma, Metastatic Breast Cancer, Metastatic Lobular Breast Carcinoma, Metastatic Breast Carcinoma
Sponsor: AstraZeneca. Phase: PHASE2. Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: Lakefront Biotherapeutics NV. Phase: PHASE2. Conditions: Systemic Lupus Erythematosus
Sponsor: AbbVie. Phase: PHASE3. Conditions: Myelodysplastic Syndrome (MDS)
Sponsor: Grünenthal GmbH. Phase: PHASE1. Conditions: Duchenne Muscular Dystrophy (DMD)
Sponsor: University of Southern California. Phase: PHASE1. Conditions: Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Liver, Refractory Malignant Solid Neoplasm, Stage III Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8
Sponsor: Shanghai Henlius Biotech. Phase: PHASE1. Conditions: Esophageal and/or Cardia Cancer, Melanoma, Urothelial Carcinoma (UC)